Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells

Cancer stem-like cell (CS-like cell) is considered to be responsible for recurrence and drug resistance events in breast cancer, which makes it a potential target for novel cancer therapeutic strategy. The FDA approved flubendazole, has been widely used in the treatment of intestinal parasites. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Zhi-Jie, Luo, Xi, Zhang, Wei, Peng, Fei, Cui, Bai, Wu, Si-Jin, Zheng, Fei-Meng, Xu, Jie, Xu, Ling-Zhi, Long, Zi-Jie, Wang, Xue-Ting, Li, Guo-Hui, Wan, Xian-Yao, Yang, Yong-Liang, Liu, Quentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467440/
https://www.ncbi.nlm.nih.gov/pubmed/25811972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467440/
https://www.ncbi.nlm.nih.gov/pubmed/25811972

Ejemplares similares